When we stratified patients according to disease duration, the subgroup with fewer than 5 years from symptoms onset showed a trend toward higher levels of C5 ( p = 0.057) and lower levels of C3 ( p = 0.06) in patients with higher clinical severity on the ADL scale.
Moreover, the LC group showed a trend toward a decrease in leukocyte number (white blood cell; P = 0.057).
In pregnancies complicated by a syndromic diagnosis, there was no direct effect of RoR or SES on the rate of TOP, but a lower Chan SES index score was indirectly associated with a lower rate of TOP, mediated by GA at diagnosis ( P = 0.02), and greater RoR showed a trend toward a similar effect ( P = 0.057) (Table 3 ).
For the patients receiving IVT followed by endovascular therapy, SHypo showed a trend for predicting 3-month poor outcome (adjusted OR, 0.27; 95% CI, 0.08–1.06; P = 0.057), but not for END and mortality.
Patients with bZIP in-f CEBPA showed a lower relapse rate than those with CEBPA wild (p < 0.001); they also showed a trend of a lower CIR than those with non-bZIP in-f CEBPA (p=0.057).
The use of the median vein also showed a trend toward increased risk (OR = 1.84; P = 0.057), although this finding did not reach statistical significance.
WM reduced leptin levels ( p = 0.017), and LFC showed a trend to reduce leptin ( p = 0.057).
GABA-currents recorded in KO UNT-oocytes showed a trend towards a decrease with respect to WT UNT-injected oocytes ( Fig. 6f , WT UNT, 100 ± 3.51%, n = 90; KO UNT, 87.21 ± 5.93%, n = 77, p = 0.057), while EC 50 and n H ( Fig. 6g ) remained similar (WT UNT, EC 50 = 93.74 ± 5.21 μM, n H = 1.16 ± 0.05, n = 13; KO UNT, EC 50 = 97.8 ± 4.30 μM, n H = 1.24 ± 0.06, n = 18).
Cases that harbored an EBF1 deletion showed a trend towards higher MRD levels after induction therapy compared to non- EBF1 deleted cases (OR = 5.16, p = 0.057; Fig. 3B ).
Male B6.Del16 +/ Bdh1-Tfrc mice showed a trend towards increased latency that did not reach significance (main effect of genotype, F 1, 28 = 3.922, p = 0.057), swam a greater distance (main effect of genotype, F 1, 28 = 4.621, p < 0.05), but had similar swim speed (main effect of genotype, F 1, 28 = 0.493, p > 0.05) to reach the hidden platform on day 5 compared with B6.WT littermates (Supplemental Fig. 5d–f ).
Overall, effects of variable timing cues showed a trend toward being smaller than those of fixed timing cues (t 27 = 1.99, p = 0.057, comparing responses to any fixed timing CS to those evoked by any variable timing CS), rendering it possible that any effects were too small for such a scaling to be detectable.
Mann-Whitney’s U-test showed that the drawing scores were significantly lower in AD patients for the images (bottom figures of Figure 1 ; Image 1, AD 2.81 ± 1.38, control 4.75 ± 0.77, p < 0.001; Image 2, AD 1.88 ± 1.09, control 3.56 ± 0.81, p < 0.001; Image 4, AD 1.69 ± 1.66, control 5.94 ± 2.77, p < 0.001) except for image 3, in which the difference showed a trend (AD 3.25 ± 2.58, control 5.19 ± 3.04, p = 0.057).
Busulfan exposure < 59.5 mg × h/L showed a trend toward a higher risk of TRM than exposure ≥59.5 mg × h/L (HR, 0.5; 95% CI, 0.26-0.99; P = .057).
In 33 cases, both b-PET and r-PET were available to obtain ΔSUVMax, and this showed a trend toward correlation with aNHL transformation (median ΔSUVMax was +67% in transformation vs +9% without transformation, P = .057), limited by sample size.
Overall, the T cell repertoire of MDD patients showed a trend for higher Gini-TCR indices in CD4 + cells ( p = 0.057; Figure 5 A), indicating that the CD4 + TCR repertoire might be less evenly distributed in MDD.
A clear dependency of the extracted parameters on the ambient pressure change could be confirmed, except in corneal strain, which showed a trend ( p = 0.057) only.
Levetiracetam showed a trend for the suppression of the P180 ( p = 0.057).
TNF‐α showed a trend toward increased levels between Pfirrmann grades 3 and 4 ( p = 0.057).
Patients showed significant improvements in maximal achieved power at termination of the test (9% increase, 16 W, P = 0.025), while healthy controls showed a trend toward improvement (6%, 13 W, P = 0.057).[ 27 ] Cognitive function Improvement in short-term memory (STM) scores for combined exercise and nonexercise schizophrenia groups was correlated with change in hippocampal volume (r = 0.51; P < .05).
Interestingly, remibrutinib treatment showed a trend for reduction in PMA/ionomycin-induced Th17 CD4 + frequencies (Fig. 3 c, p = 0.057 and p = 0.072 for 3 and 30 mg/kg dose, respectively.
Although overweight status (BMI >25.0) was not significantly different between the two IBS clusters, IBS1 [m(sd), 25.52 (5.68)] showed a trend ( t (27) = 1,99, p = .057) toward greater BMI compared to HC-like IBS [20.99 (6.51)], Hedge’s effect size g (Cohen’s d corrected for small sample sizes) = .74.
When the association between DPB1 and GPA/PR3-AAV was examined, DPB1*04 : 01 (the risk allele for GPA in European populations) also showed a trend for association with predisposition to PR3-AAV in the Japanese population (P = 0.057, OR = 1.89, 95%CI: 1.03–3.45) ( Table 4 ).
In line with the published literature, the present study also showed a trend ( p = 0.057) towards higher prevalence of heart failure among subjects with persistent atrial fibrillation and its related treatment (e.g., digitalis and ACEI/ARB).
The post-surgery group presented a significantly higher ratio (2.88 ± 15.74) in relation to the pre-surgery group (p < 0.05) and showed a trend towards a higher ratio when compared to the control (p = 0.057).
BRAF mutated implants showed a trend (p = 0,057) of higher overall p16 immunoreactivity though no such relation was observed for p53.